Are Wall Street Analysts Bullish on Colgate-Palmolive Stock?

Core Viewpoint - Colgate-Palmolive Company is a leading global consumer goods firm with a market cap of $72.8 billion, specializing in oral care, personal care, home care, and pet nutrition products, operating in over 200 countries and territories [1] Financial Performance - For fiscal Q4 2025, Colgate reported net sales of $5.23 billion, a 5.8% year-over-year increase, with organic sales up 2.2% despite challenges from exiting private-label pet food [4] - The company's full-year net sales reached a record $20.38 billion, reflecting a 1.4% increase, supported by strong cash flow and significant shareholder returns through dividends and buybacks [4] - Analysts project a 4.6% year-over-year increase in EPS for FY2026, estimating it to be $3.86, with a history of surpassing earnings expectations in the past four quarters [4] Stock Performance - Colgate's shares have underperformed the broader market, declining 14.3% year-to-date, while the S&P 500 Index has increased by 1.4% in the same period [2] - The stock has also lagged behind the State Street Consumer Staples Select Sector SPDR Fund, which rose 4.7% over the past 52 weeks [3] Analyst Ratings - The stock holds a consensus "Moderate Buy" rating, with 21 analysts providing coverage, including nine "Strong Buys," three "Moderate Buys," eight "Holds," and one "Strong Sell" [5] - Recently, JPMorgan Chase analyst raised the price target on Colgate-Palmolive to $93 from $88, reflecting a 5.7% increase and maintaining an "Overweight" rating, indicating confidence in the company's market position and growth prospects [7]